---
title: "Gyre Therapeutics (GYRE) 獲得了 Noble Financial 的買入評級"
description: "LeBoyer 涉及醫療保健行業，專注於 Ocugen、Eledon Pharmaceuticals 和 Unicycive Therapeutics 等股票。根據 TipRanks 的數據，LeBoyer 的平均回報率為 -10.6%，推薦股票的成功率為 26.51%。市場普遍認為，Gyre Therapeutics 的分析師共識評級為強烈買入，平均目標價為 23.00 美元，較當前水平有 19"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/256588476.md"
published_at: "2025-09-09T13:55:13.000Z"
---

# Gyre Therapeutics (GYRE) 獲得了 Noble Financial 的買入評級

> LeBoyer 涉及醫療保健行業，專注於 Ocugen、Eledon Pharmaceuticals 和 Unicycive Therapeutics 等股票。根據 TipRanks 的數據，LeBoyer 的平均回報率為 -10.6%，推薦股票的成功率為 26.51%。市場普遍認為，Gyre Therapeutics 的分析師共識評級為強烈買入，平均目標價為 23.00 美元，較當前水平有 190.77% 的上漲空間。在 8 月 26 日發佈的一份報告中，H.C. Wainwright 也對該股票進行了覆蓋，並給予買入評級，目標價為 18.00 美元

LeBoyer 涉及醫療保健行業，專注於 Ocugen、Eledon Pharmaceuticals 和 Unicycive Therapeutics 等股票。根據 TipRanks 的數據，LeBoyer 推薦股票的平均回報為 -10.6%，成功率為 26.51%。

市場普遍認為，Gyre Therapeutics 的分析師共識評級為強烈買入，平均目標價為 23.00 美元，較當前水平有 190.77% 的上漲空間。在 8 月 26 日發佈的一份報告中，H.C. Wainwright 也對該股票進行了覆蓋，給予買入評級，目標價為 18.00 美元。

### Related Stocks

- [GYRE.US - Gyre Therapeutics](https://longbridge.com/zh-HK/quote/GYRE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Gyre Therapeutics (GYRE) Gets a Buy from H.C. Wainwright | Keller covers the Healthcare sector, focusing on stocks such as FibroGen, Acurx Pharmaceuticals, and Gyre Therapeutics.  | [Link](https://longbridge.com/zh-HK/news/263275045.md) |
| Palvella Therapeutics (PVLA) Gets a Buy from Craig-Hallum | In a recent report, Craig-Hallum analyst Albert Lowe maintained a Buy rating on Palvella Therapeutics (PVLA) with a pric | [Link](https://longbridge.com/zh-HK/news/276240277.md) |
| CNL Healthcare Sets NAV, Details Sonida Merger Plans | CNL Healthcare Properties has set an adjusted estimated net asset value (NAV) of $6.90 per share as of November 4, 2025, | [Link](https://longbridge.com/zh-HK/news/276164395.md) |
| Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-HK/news/275986113.md) |
| A Look At Acadia Healthcare (ACHC) Valuation After David Einhorn Stake And Leadership Changes | Acadia Healthcare (ACHC) gained attention after David Einhorn disclosed a new stake, leading to increased trading volume | [Link](https://longbridge.com/zh-HK/news/275994576.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。